About Biograil
Biograil is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDD technology to unlock the potential of transforming the tremendous market of injectable pharmaceutical products into convenient oral capsules.
Facts about Biograil
Facts about Biograil
- Founding: 2019
- Focus : Manufacturer
- Industry : Biotechnology, Pharma
Advertisement
Product portfolio of Biograil
News about Biograil
Here you will find Biograil ApS
Last viewed contents
Hybridize Therapeutics - Leiden, Netherlands
SOLID Therapeutics - Copenhagen, Denmark
Genicity - Newcastle, Galway, United Kingdom
Heqet Therapeutics - Torino, Italy
Merck Life Science KGaA - Darmstadt, Germany
StratifAI Raises €12.5M for Clinical Validation of AI Biomarker Platform for Precision Oncology - Oversubscribed round expand global reach, and unlock multi‑billion‑euro cancer diagnostics market
Simply taste your way to flu infection - Rapid test for influenza viruses using chewing gum – without the need for a laboratory, electricity or medical personnel
Transparent artificial intelligence improves assessment of prostate cancer aggressiveness - AI speaks the language of pathologists
New nanosensors make diagnostic procedures more sensitive - The nanosensors can be used to track reactions with invisible light, saving materials and time
Cyber Valley grants 500K to CELL’n’ROLL via 2023 Innovation Fellowship Program - Cyber Valley Community is advancing diagnostics for the future: Its goal is to create an innovative spin-off from the project after the funding term has ended
Blood diagnostics modelled on leeches - For all those who are afraid of needles: New device for taking blood samples uses microneedles and a suction cup instead of a large needle
